CL2017000016A1 - Administración intradérmica de una composición de inmunoglobulina g. - Google Patents
Administración intradérmica de una composición de inmunoglobulina g.Info
- Publication number
- CL2017000016A1 CL2017000016A1 CL2017000016A CL2017000016A CL2017000016A1 CL 2017000016 A1 CL2017000016 A1 CL 2017000016A1 CL 2017000016 A CL2017000016 A CL 2017000016A CL 2017000016 A CL2017000016 A CL 2017000016A CL 2017000016 A1 CL2017000016 A1 CL 2017000016A1
- Authority
- CL
- Chile
- Prior art keywords
- intradermal administration
- immunoglobulin composition
- immunoglobulin
- composition
- intradermal
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662292075P | 2016-02-05 | 2016-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2017000016A1 true CL2017000016A1 (es) | 2017-06-16 |
Family
ID=57944251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2017000016A CL2017000016A1 (es) | 2016-02-05 | 2017-01-05 | Administración intradérmica de una composición de inmunoglobulina g. |
Country Status (18)
Country | Link |
---|---|
US (2) | US20170226191A1 (es) |
EP (1) | EP3202393B1 (es) |
JP (1) | JP7033848B2 (es) |
KR (1) | KR20170093704A (es) |
CN (1) | CN107041953A (es) |
AR (1) | AR107295A1 (es) |
AU (1) | AU2017200007B2 (es) |
CA (1) | CA2953543A1 (es) |
CL (1) | CL2017000016A1 (es) |
ES (1) | ES2929631T3 (es) |
IL (1) | IL249795B (es) |
MX (1) | MX2017000268A (es) |
MY (1) | MY198746A (es) |
PL (1) | PL3202393T3 (es) |
RU (1) | RU2762499C2 (es) |
SG (1) | SG10201700022QA (es) |
TW (1) | TWI791425B (es) |
UY (1) | UY37061A (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7025144B2 (ja) * | 2017-07-13 | 2022-02-24 | 株式会社メガチップス | 電子メロディ特定装置、プログラム、及び電子メロディ特定方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8658773B2 (en) * | 2011-05-02 | 2014-02-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
AU2004270113A1 (en) * | 2003-08-26 | 2005-03-17 | Becton, Dickinson And Company | Methods for intradermal delivery of therapeutics agents |
US20050196380A1 (en) * | 2004-03-08 | 2005-09-08 | Mikszta John A. | Method for delivering therapeutic proteins to the intradermal compartment |
TWI489994B (zh) * | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
JP2016515515A (ja) * | 2013-03-15 | 2016-05-30 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 抗プロラクチン受容体抗体製剤 |
-
2016
- 2016-12-27 IL IL249795A patent/IL249795B/en active IP Right Grant
-
2017
- 2017-01-02 UY UY0001037061A patent/UY37061A/es not_active Application Discontinuation
- 2017-01-03 SG SG10201700022QA patent/SG10201700022QA/en unknown
- 2017-01-03 AU AU2017200007A patent/AU2017200007B2/en active Active
- 2017-01-03 EP EP17150114.1A patent/EP3202393B1/en active Active
- 2017-01-03 MY MYPI2017700009A patent/MY198746A/en unknown
- 2017-01-03 PL PL17150114.1T patent/PL3202393T3/pl unknown
- 2017-01-03 CA CA2953543A patent/CA2953543A1/en active Pending
- 2017-01-03 ES ES17150114T patent/ES2929631T3/es active Active
- 2017-01-05 MX MX2017000268A patent/MX2017000268A/es unknown
- 2017-01-05 CL CL2017000016A patent/CL2017000016A1/es unknown
- 2017-01-05 AR ARP170100019A patent/AR107295A1/es unknown
- 2017-01-11 CN CN201710018106.8A patent/CN107041953A/zh active Pending
- 2017-01-12 RU RU2017100665A patent/RU2762499C2/ru active
- 2017-01-12 JP JP2017003151A patent/JP7033848B2/ja active Active
- 2017-01-12 KR KR1020170004993A patent/KR20170093704A/ko unknown
- 2017-01-16 TW TW106101375A patent/TWI791425B/zh active
- 2017-01-16 US US15/407,139 patent/US20170226191A1/en not_active Abandoned
-
2020
- 2020-02-28 US US16/805,425 patent/US20200199201A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN107041953A (zh) | 2017-08-15 |
AU2017200007B2 (en) | 2023-07-06 |
EP3202393A1 (en) | 2017-08-09 |
JP2017137297A (ja) | 2017-08-10 |
CA2953543A1 (en) | 2017-08-05 |
PL3202393T3 (pl) | 2022-12-19 |
US20170226191A1 (en) | 2017-08-10 |
MY198746A (en) | 2023-09-22 |
KR20170093704A (ko) | 2017-08-16 |
RU2017100665A3 (es) | 2020-05-20 |
EP3202393B1 (en) | 2022-08-31 |
RU2017100665A (ru) | 2018-07-16 |
RU2762499C2 (ru) | 2021-12-21 |
ES2929631T3 (es) | 2022-11-30 |
IL249795A0 (en) | 2017-03-30 |
IL249795B (en) | 2020-01-30 |
AR107295A1 (es) | 2018-04-18 |
MX2017000268A (es) | 2018-07-04 |
AU2017200007A1 (en) | 2017-08-24 |
SG10201700022QA (en) | 2017-09-28 |
UY37061A (es) | 2017-03-31 |
TWI791425B (zh) | 2023-02-11 |
US20200199201A1 (en) | 2020-06-25 |
TW201728338A (zh) | 2017-08-16 |
JP7033848B2 (ja) | 2022-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3688162T3 (da) | Formuleringer | |
DK3697376T3 (da) | Sammensætning | |
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
BR112016023628A2 (pt) | composições farmacêuticas. | |
DK3474804T4 (da) | Medicinsk forbinding | |
DK3416996T3 (da) | Hærdelig sammensætning | |
MA50657A (fr) | Formulations de niraparib | |
DK3528902T3 (da) | Ringegelsammensætning | |
DK3591007T3 (da) | Termoplastisk sammensætning | |
CL2018001711A1 (es) | Composición de pasta dental. | |
DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron | |
KR20180085041A (ko) | 칫솔 | |
DK3463553T3 (da) | Unipolar kanyle | |
DK3393254T3 (da) | Sammensætning | |
MA50068A (fr) | Formulations de copanlisib | |
DK3528791T3 (da) | Dispergible sammensætninger | |
DK3452093T3 (da) | Ophthalmiske sammensætninger | |
DK3416502T3 (da) | Glykæmisk-reducerende sammensætning | |
FR3048181B1 (fr) | Composition hydroalcoolique opaque | |
BR112017016240A2 (pt) | composição | |
ES1209313Y (es) | Composicion liofilizada | |
KR20180084728A (ko) | 구강용 조성물 | |
FI20160183L (fi) | Parannettu puolijohdekokoonpano | |
ITUA20163470A1 (it) | Formulazione antiappannante | |
CL2017000016A1 (es) | Administración intradérmica de una composición de inmunoglobulina g. |